• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟核苷类抗生素穆雷多霉素A氨基末端肽链的5'-尿苷二肽类似物的合成与活性

Synthesis and activity of 5'-uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A.

作者信息

Howard Nigel I, Bugg Timothy D H

机构信息

Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.

出版信息

Bioorg Med Chem. 2003 Jul 17;11(14):3083-99. doi: 10.1016/s0968-0896(03)00270-0.

DOI:10.1016/s0968-0896(03)00270-0
PMID:12818671
Abstract

A series of 5'-uridinyl dipeptides were synthesised which mimic the amino terminal chain of nucleoside antibiotic mureido omycin A. Aminoacyl-beta-alanyl- and aminoacyl-N-methyl-beta-alanyl- dipeptides were attached either via an ester linkage to the 5'-hydroxyl of uridine, or via an amide linkage to 5'-amino-5'-deoxyuridine. The most active inhibitor of Escherichia coli phospho-MurNAc-pentapeptide translocase (MraY) was 5'-O-(L-Ala-N-methyl-beta-alanyl)-uridine (13l), which also showed 97% enzyme inhibition at 2.35 mM concentration, and showed antibacterial activity at 100 microg/mL concentration against Pseudomonas putida. Both the central N-methyl amide linkage and a 5' uridine ester linkage were required for highest biological activity. Enzyme inhibition was shown to be competitive with Mg(2+). It is proposed that the primary amino terminus of the inhibitor binds in place of the Mg(2+) cofactor at the MraY active site, positioned via a cis-N-methyl amide linkage.

摘要

合成了一系列5'-尿苷二肽,它们模拟核苷抗生素多聚霉素A的氨基末端链。氨酰基-β-丙氨酰基-和氨酰基-N-甲基-β-丙氨酰基-二肽通过酯键连接到尿苷的5'-羟基上,或者通过酰胺键连接到5'-氨基-5'-脱氧尿苷上。大肠杆菌磷酸化MurNAc-五肽转位酶(MraY)最有效的抑制剂是5'-O-(L-丙氨酰基-N-甲基-β-丙氨酰基)-尿苷(13l),其在2.35 mM浓度下也表现出97%的酶抑制率,并且在100 μg/mL浓度下对恶臭假单胞菌具有抗菌活性。最高生物活性需要中央N-甲基酰胺键和5'尿苷酯键。酶抑制作用显示与Mg(2+)具有竞争性。据推测,抑制剂的伯氨基末端在MraY活性位点取代Mg(2+)辅因子结合,通过顺式-N-甲基酰胺键定位。

相似文献

1
Synthesis and activity of 5'-uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A.模拟核苷类抗生素穆雷多霉素A氨基末端肽链的5'-尿苷二肽类似物的合成与活性
Bioorg Med Chem. 2003 Jul 17;11(14):3083-99. doi: 10.1016/s0968-0896(03)00270-0.
2
Elucidating the Structural Requirement of Uridylpeptide Antibiotics for Antibacterial Activity.阐明尿嘧啶肽抗生素发挥抗菌活性的结构要求。
J Med Chem. 2020 Sep 10;63(17):9803-9827. doi: 10.1021/acs.jmedchem.0c00973. Epub 2020 Aug 17.
3
Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.细菌细胞壁合成中脂质I生成抑制作用的结构见解
Nature. 2016 May 26;533(7604):557-560. doi: 10.1038/nature17636. Epub 2016 Apr 18.
4
The inhibition of peptidyl transferase activity by aminoacyl derivatives of some nucleoside aliphatic analogues.某些核苷脂肪族类似物的氨酰基衍生物对肽基转移酶活性的抑制作用。
Nucleic Acids Res. 1974 Oct;1(10):1221-31. doi: 10.1093/nar/1.10.1221.
5
Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.核苷类天然产物抗生素、噬菌体ϕX174裂解蛋白E和阳离子抗菌肽对磷酸化的胞壁酰五肽转运酶(MraY)的抑制作用
Bioorg Med Chem. 2016 Dec 15;24(24):6340-6347. doi: 10.1016/j.bmc.2016.03.018. Epub 2016 Mar 9.
6
Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.衣霉素、脂多霉素B和多醚霉素A的作用模式:抑制大肠杆菌的磷酸-N-乙酰胞壁酰-五肽转位酶
Antimicrob Agents Chemother. 1996 Jul;40(7):1640-4. doi: 10.1128/AAC.40.7.1640.
7
Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship.抑制磷酸化胞壁酰五肽转位酶的抗菌核苷天然产物;化学与构效关系
Curr Med Chem. 2015;22(34):3951-79. doi: 10.2174/0929867322666150818103502.
8
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.卡泊芬净:作用于新型抗菌靶点 MraY 的有前景的先导结构。
Eur J Med Chem. 2019 Jun 1;171:462-474. doi: 10.1016/j.ejmech.2019.01.071. Epub 2019 Mar 20.
9
Mechanism of action of nucleoside antibacterial natural product antibiotics.核苷类抗菌天然产物抗生素的作用机制。
J Antibiot (Tokyo). 2019 Dec;72(12):865-876. doi: 10.1038/s41429-019-0227-3. Epub 2019 Aug 30.
10
Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.通过文库筛选鉴定磷酸化胞壁酰五肽转运酶MraY的新型抑制剂:异喹啉生物碱米氏胺B和呫吨染料焰红染料B。
Bioorg Med Chem. 2014 Sep 1;22(17):4566-71. doi: 10.1016/j.bmc.2014.07.035. Epub 2014 Jul 27.

引用本文的文献

1
A comprehensive computational study to explore promising natural bioactive compounds targeting glycosyltransferase MurG in Escherichia coli for potential drug development.一项全面的计算研究,旨在探索针对大肠杆菌糖基转移酶 MurG 的有前途的天然生物活性化合物,以用于潜在药物开发。
Sci Rep. 2024 Mar 26;14(1):7098. doi: 10.1038/s41598-024-57702-x.
2
N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity.N- 烷基三苯乙烯基吡啶鎓二氢青蒿素干扰线粒体功能,导致增强的癌症与正常细胞毒性。
Free Radic Biol Med. 2021 Mar;165:421-434. doi: 10.1016/j.freeradbiomed.2021.01.050. Epub 2021 Feb 6.
3
Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.
细菌 MraY 和人类 GPT 的结构为合理设计抗生素提供了线索。
J Mol Biol. 2020 Aug 21;432(18):4946-4963. doi: 10.1016/j.jmb.2020.03.017. Epub 2020 Mar 19.
4
Mechanism of action of nucleoside antibacterial natural product antibiotics.核苷类抗菌天然产物抗生素的作用机制。
J Antibiot (Tokyo). 2019 Dec;72(12):865-876. doi: 10.1038/s41429-019-0227-3. Epub 2019 Aug 30.
5
Chemical logic of MraY inhibition by antibacterial nucleoside natural products.抗菌核苷天然产物抑制 MraY 的化学逻辑。
Nat Commun. 2019 Jul 2;10(1):2917. doi: 10.1038/s41467-019-10957-9.
6
Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.血管内皮生长因子受体(VEGFR)抑制剂舒尼替尼的组织蛋白酶B可裂解前药的合成、表征及体外研究
Chem Biodivers. 2019 Jan;16(1):e1800520. doi: 10.1002/cbdv.201800520. Epub 2018 Dec 19.
7
Bacterial phosphoglycosyl transferases: initiators of glycan biosynthesis at the membrane interface.细菌磷酸糖基转移酶:膜界面聚糖生物合成的起始者。
Glycobiology. 2017 Sep 1;27(9):820-833. doi: 10.1093/glycob/cwx064.
8
Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis.三杉霉素天然产物类似物作为强效和选择性的抗分枝杆菌化合物,抑制脂质 I 生物合成。
Nat Commun. 2017 Mar 1;8:14414. doi: 10.1038/ncomms14414.
9
The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic Targets.细菌细胞壁合成的膜阶段作为抗生素靶标。
Antibiotics (Basel). 2016 Aug 26;5(3):28. doi: 10.3390/antibiotics5030028.
10
Improving the N-terminal diversity of sansanmycin through mutasynthesis.通过突变合成改善三光霉素的N端多样性。
Microb Cell Fact. 2016 May 6;15:77. doi: 10.1186/s12934-016-0471-1.